Gland Pharma Limited (NSE:GLAND)

India · Delayed Price · Currency is INR

1,853.10

+16.80 (0.91%)

Feb 18, 2026, 1:30 PM IST

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017
Generic Injectibles	56.17B
Generic Injectibles Growth	-0.85%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017
United States	27.40B
United States Growth	1.95%
Rest of World	11.38B
Rest of World Growth	-3.72%
Europe	10.23B
Europe Growth	-2.88%
India	4.77B
India Growth	-18.95%
Canada	1.57B
Canada Growth	76.83%
Australia	742.94M
Australia Growth	18.60%
New Zealand	77.23M
New Zealand Growth	174.16%